Cargando…
Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma
Remdesivir, formerly GS-5734, has recently become the first antiviral drug approved by the U.S. Food and Drug Administration (FDA) to treat COVID-19, the disease caused by SARS-CoV-2. Therapeutic dosing and pharmacokinetic studies require a simple, sensitive, and selective validated assay to quantif...
Autores principales: | Nguyen, Ryan, Goodell, Jennifer C., Shankarappa, Priya S., Zimmerman, Sara, Yin, Tyler, Peer, Cody J., Figg, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944857/ https://www.ncbi.nlm.nih.gov/pubmed/33756448 http://dx.doi.org/10.1016/j.jchromb.2021.122641 |
Ejemplares similares
-
Fast and Simple LC-MS/MS Method for Rifampicin Quantification in Human Plasma
por: Temova Rakuša, Žane, et al.
Publicado: (2019) -
A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma
por: Schwarz, Rico, et al.
Publicado: (2022) -
A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid
por: Sidhu, Rohini, et al.
Publicado: (2015) -
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
por: Zanchetta, Martina, et al.
Publicado: (2021) -
Quantification of cGMP in human plasma by isotope dilution LC-MS/MS
por: Martens-Lobenhoffer, Jens, et al.
Publicado: (2009)